| Sep 13 |
TEVA Stock Rises 72.5% This Year: Time to Buy, Sell or Hold?
|
| Sep 11 |
Teva to Present at the Bank of America 2024 Global Healthcare Conference
|
| Sep 10 |
Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial
|
| Sep 10 |
Sector Update: Health Care Stocks Advance Late Afternoon
|
| Sep 10 |
Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic
|
| Sep 10 |
Update: Teva Pharmaceutical Faces Fine in EU for Dismissive Tactics Against Rivals
|
| Sep 10 |
Teva facing EU fine for disparaging Copaxone rival: report
|
| Sep 9 |
Cheap Teva Stock Should Reward Patient Investors
|
| Sep 6 |
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
|
| Sep 5 |
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
|
